Article Details
Retrieved on: 2018-01-15 22:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>On its way to developing a universal flu vaccine, University of Oxford spinout Vaccitech has raised £20 million ($27 million) in series A financing, backed by Alphabet's venture capital arm GV (formerly <b>Google Ventures</b>), Sequoia China and Oxford Sciences Innovation. The £20 million, together with the ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here